DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Combined vasomodulatory therapy for severe pulmonary hypertension in chronic hypersensitivity pneumonitis.

Author(s): Koschel DS, Kolditz M, Hoeffken G, Halank M

Affiliation(s): Department of Pulmonary Diseases, Fachkrankenhaus Coswig, Centre for Pulmonary Diseases and Thoracic Surgery, Coswig, Germany. dr.koschel@fachkrankenhaus-coswig.de

Publication date & source: 2010-04-28, Med Sci Monit., 16(5):CS55-7.

Publication type: Case Reports

BACKGROUND: There are only a few reports of pulmonary hypertension (PH) in hypersensitivity pneumonitis (HP) and an approved vasomodulatory therapy for PH does not exist at all for interstitial lung disease (ILD), particularly for HP. CASE REPORT: The case of a 53-year-old woman with chronic HP and severe life-threatening PH treated with a combined specific vasomodulatory therapy is reported. Sustained clinical and hemodynamic improvement was achieved. CONCLUSIONS: Further investigation of PH in HP and specific vasomodulatory therapy is necessary.

Page last updated: 2010-10-05

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017